About
Atara Biotherapeutics develops allogeneic T-cell immunotherapies derived from healthy donors to treat cancer and autoimmune diseases, focusing on scalable, off-the-shelf cellular therapies.
Explore Atara Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.